ArticleNPJ precision oncology2021

A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer.

Natalia J Gurule et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.